Trends & Forecasts

Sitting Down With… Tony van Bijleveld, BU Head of Softgels, Pharma Services Group, Thermo Fisher Scientific, the Netherlands.

New cancer treatments may be lying right under our noses – if we are willing to take a commercial risk.

Who will be chosen for The Medicine Maker 2018 Power List? The power is in your hands.

The year 2018 will be one of yet more drug approvals, but which areas will be neglected?

Addressing the opioid crisis, 3D printing drug guidelines, and execution drugs…

Sitting Down With… Richard Markus, Vice President of Global Development, Amgen, USA

Can we predict the impact Brexit will have on UK life sciences?

A Spotlight Interview with... Kishor Wasan, Dean of the College of Pharmacy and Nutrition, University of Saskatchewan, Canada.

Iraq war victims accuse several pharma companies of aiding and abetting a terrorist group.

Healthcare Futurist Joe Flower gives his views on how pharma can avoid a dystopian future.